{"id":"https://openalex.org/W2947776589","doi":"https://doi.org/10.1002/pst.1952","title":"Detecting bliss synergy in in vivo combination studies with a tumor kinetic model","display_name":"Detecting bliss synergy in in vivo combination studies with a tumor kinetic model","publication_year":2019,"publication_date":"2019-05-29","ids":{"openalex":"https://openalex.org/W2947776589","doi":"https://doi.org/10.1002/pst.1952","mag":"2947776589","pmid":"https://pubmed.ncbi.nlm.nih.gov/31140720"},"language":"en","primary_location":{"id":"doi:10.1002/pst.1952","doi":"https://doi.org/10.1002/pst.1952","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pst.1952","pdf_url":null,"source":{"id":"https://openalex.org/S141766756","display_name":"Pharmaceutical Statistics","issn_l":"1539-1604","issn":["1539-1604","1539-1612"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Statistics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100710534","display_name":"Wei Zhao","orcid":"https://orcid.org/0000-0003-3361-4677","observed_orcids":["https://orcid.org/0000-0003-3361-4677"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Wei Zhao","raw_affiliation_strings":["Statistical Sciences, AstraZeneca PLC, Cambridge, UK"],"raw_orcid":"https://orcid.org/0000-0003-3361-4677","affiliations":[{"raw_affiliation_string":"Statistical Sciences, AstraZeneca PLC, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103510991","display_name":"Paolo Vicini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paolo Vicini","raw_affiliation_strings":["Clinical Pharmacology, AstraZeneca PLC, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, AstraZeneca PLC, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042841642","display_name":"Steven J. Novick","orcid":"https://orcid.org/0000-0001-8760-1519","observed_orcids":["https://orcid.org/0000-0001-8760-1519"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Steven Novick","raw_affiliation_strings":["Statistical Sciences, AstraZeneca PLC, Cambridge, UK"],"raw_orcid":"https://orcid.org/0000-0001-8760-1519","affiliations":[{"raw_affiliation_string":"Statistical Sciences, AstraZeneca PLC, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045599189","display_name":"Judith Anderton","orcid":"https://orcid.org/0000-0002-8816-1196","observed_orcids":["https://orcid.org/0000-0002-8816-1196"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Judith Anderton","raw_affiliation_strings":["Oncology Research, AstraZeneca PLC, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research, AstraZeneca PLC, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101687947","display_name":"Gareth M. Davies","orcid":"https://orcid.org/0000-0002-3324-4154","observed_orcids":["https://orcid.org/0000-0002-3324-4154"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gareth Davies","raw_affiliation_strings":["Oncology Research, AstraZeneca PLC, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research, AstraZeneca PLC, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073976995","display_name":"Gina D\u2019Angelo","orcid":"https://orcid.org/0000-0002-5327-086X","observed_orcids":["https://orcid.org/0000-0002-5327-086X"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gina DAngelo","raw_affiliation_strings":["Statistical Sciences, AstraZeneca PLC, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical Sciences, AstraZeneca PLC, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060139470","display_name":"Terrance O'Day","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Terrance O'Day","raw_affiliation_strings":["Statistical Sciences, AstraZeneca PLC, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical Sciences, AstraZeneca PLC, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032118390","display_name":"Binbing Yu","orcid":"https://orcid.org/0000-0003-3647-5852","observed_orcids":["https://orcid.org/0000-0003-3647-5852"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Binbing Yu","raw_affiliation_strings":["Statistical Sciences, AstraZeneca PLC, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical Sciences, AstraZeneca PLC, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103843714","display_name":"Jay W. Harper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jay Harper","raw_affiliation_strings":["Oncology Research, AstraZeneca PLC, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research, AstraZeneca PLC, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110048076","display_name":"Rajesh Narwal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rajesh Narwal","raw_affiliation_strings":["Clinical Pharmacology, AstraZeneca PLC, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, AstraZeneca PLC, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069627913","display_name":"Lorin K. Roskos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lorin Roskos","raw_affiliation_strings":["Clinical Pharmacology, AstraZeneca PLC, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, AstraZeneca PLC, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020601958","display_name":"Harry Yang","orcid":"https://orcid.org/0009-0008-8758-5705","observed_orcids":["https://orcid.org/0009-0008-8758-5705"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Harry Yang","raw_affiliation_strings":["Statistical Sciences, AstraZeneca PLC, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical Sciences, AstraZeneca PLC, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5100710534"],"corresponding_institution_ids":["https://openalex.org/I105036370"],"apc_list":{"value":3600,"currency":"USD","value_usd":3600},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.04922924,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"18","issue":"6","first_page":"688","last_page":"699"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.8511000275611877,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.8511000275611877,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.13699999451637268,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10243","display_name":"Statistical Methods and Bayesian Inference","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.628000020980835},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.6840000152587891},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.5529999732971191},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.871999979019165},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9300000071525574},{"id":"https://openalex.org/keywords/mechanistic-modeling","display_name":"mechanistic modeling","score":0.6309999823570251},{"id":"https://openalex.org/keywords/differential-equations","display_name":"differential equations","score":0.8420000076293945},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6439428329467773},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4301782250404358},{"id":"https://openalex.org/C163175372","wikidata":"https://www.wikidata.org/wiki/Q3339222","display_name":"Linear model","level":2,"score":0.4130953550338745},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.4014487862586975},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2501213550567627},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.247096449136734},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.20959919691085815},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20188573002815247},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008962","descriptor_name":"Models, Theoretical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016014","descriptor_name":"Linear Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/pst.1952","doi":"https://doi.org/10.1002/pst.1952","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pst.1952","pdf_url":null,"source":{"id":"https://openalex.org/S141766756","display_name":"Pharmaceutical Statistics","issn_l":"1539-1604","issn":["1539-1604","1539-1612"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Statistics","raw_type":"journal-article"},{"id":"pmid:31140720","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31140720","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical statistics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W747827733","https://openalex.org/W1493962604","https://openalex.org/W1972877806","https://openalex.org/W1980181290","https://openalex.org/W2020676762","https://openalex.org/W2035267407","https://openalex.org/W2049977830","https://openalex.org/W2074642772","https://openalex.org/W2093223772","https://openalex.org/W2129228724","https://openalex.org/W2771328375","https://openalex.org/W4249731213"],"related_works":["https://openalex.org/W1997436317","https://openalex.org/W2049977830","https://openalex.org/W4288694721","https://openalex.org/W2161559302","https://openalex.org/W3125438236","https://openalex.org/W4387599688","https://openalex.org/W2788684488","https://openalex.org/W2057022062","https://openalex.org/W2989954637","https://openalex.org/W4416388734"],"abstract_inverted_index":{"Linear":[0],"models":[1,41,44,83,100],"are":[2,42],"generally":[3],"reliable":[4],"methods":[5],"for":[6,117],"analyzing":[7],"tumor":[8,29,47,50,81,101],"growth":[9,30,102],"in":[10,103],"vivo,":[11],"with":[12],"drug":[13,60,77],"effectiveness":[14],"being":[15],"represented":[16],"by":[17,80],"the":[18,21,76],"steepness":[19],"of":[20,56],"regression":[22],"slope.":[23],"With":[24],"immunotherapy,":[25],"however,":[26,75],"not":[27],"all":[28],"follows":[31],"a":[32,54,94],"linear":[33],"pattern,":[34],"even":[35],"after":[36],"log":[37],"transformation.":[38],"Tumor":[39],"kinetics":[40,82],"mechanistic":[43],"that":[45,98],"describe":[46],"proliferation":[48],"and":[49,106,121],"killing":[51],"macroscopically,":[52],"through":[53],"set":[55],"differential":[57],"equations.":[58],"In":[59],"combination":[61,107],"studies,":[62],"although":[63],"an":[64],"additional":[65],"drug-drug":[66],"interaction":[67],"term":[68],"can":[69],"be":[70,85],"added":[71],"to":[72,115,122],"such":[73,124],"models,":[74],"interactions":[78],"suggested":[79],"cannot":[84],"translated":[86],"directly":[87,120],"into":[88],"synergistic":[89,118],"effects.":[90],"We":[91],"have":[92],"developed":[93],"novel":[95],"statistical":[96],"approach":[97,111],"simultaneously":[99],"control,":[104],"monotherapy,":[105],"therapy":[108],"groups.":[109],"This":[110],"makes":[112],"it":[113],"possible":[114],"test":[116],"effects":[119,125],"compare":[123],"among":[126],"different":[127],"studies.":[128]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-06-07T00:00:00"}